Warren Buffett
Berkshire Hathaway
Berkshire Hathaway Portfolio 13F
Warren Buffett Holdings Activity
- Portfolio value:
- $269.93B≈ (+$34B≈)
- Previous value:
- $235.94B≈
- # of changes:
- 20
- New positions:
- 0
- Reported for:
- 31 Dec 2020 (Q4)
- Latest filing date:
- 16 Feb 2021
Berkshire Hathaway has disclosed a total of 20 changes to the portfolio in the (2020 Q4) SEC report(s): increased the number of shares of 9, decreased the number of shares of 6 and completely sold out 5 position(s).
What stocks did Warren Buffett buy in 2020 Q4?
During 2020 Q4 Warren Buffett has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (VZ) Verizon Communications Inc (added shares +151.45%), (CVX) Chevron Corp (added shares +9.55%), (ABBV) AbbVie Inc (added shares +20.07%), (MRK) Merck & Company Inc (added shares +28.10%) and (BMY) Bristol-Myers Squibb Company (added shares +11.23%).
In the 2020 Q4 report(s) the following change has been made to the top investments: (AAPL) Apple Inc (reduced shares -6.05%).
Warning: SEC insider reports detected for Berkshire Hathaway (real-time trades and ownership disclosures)
2 transactions as of 4 days ago
20 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Verizon Communications Inc
|
+151.45%
|
$58.75
|
-20.01%($47.00)
|
3.19%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
T-Mobile US Inc
|
+117.23%
|
$134.85
|
+31.51%($177.34)
|
0.26%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
Kroger Company
|
+34.25%
|
$31.76
|
+78.57%($56.72)
|
0.39%
|
2019 Q4
|
≈ 1.25 years
|
||||
|
|
Merck & Company Inc
|
+28.10%
|
$81.80
|
+56.59%($128.09)
|
0.87%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
Marsh & McLennan Companies, Inc
|
+26.77%
|
$117.00
|
+63.29%($191.06)
|
0.18%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
AbbVie Inc
|
+20.07%
|
$107.15
|
+128.53%($244.88)
|
1.01%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
Bristol-Myers Squibb Company
|
+11.23%
|
$62.03
|
+3.49%($64.19)
|
0.77%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
Chevron Corp
|
+9.55%
|
$84.45
|
+121.79%($187.30)
|
1.52%
|
2020 Q3
|
≈ 0.50 years
|
||||
|
|
RH
|
+1.42%
|
$447.52
|
-56.30%($195.55)
|
0.29%
|
2019 Q3
|
≈ 1.50 years
|
||||
|
|
U.S. Bancorp
|
-0.62%
|
$46.59
|
+37.28%($63.96)
|
2.26%
|
2013 Q2 or earlier
|
≈ 7.75+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.